XFOR earnings: next report 2026-08-06, real EPS beat/miss history, analyst consensus Buy, P/E -0.81. Updated 2026-07-23.
X4 Pharmaceuticals (XFOR) Research Hub
X4 Pharmaceuticals (XFOR) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 3.5 USD (-2.78%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.81, market cap 0.35B. This hub links to the full technical, earnings and options research available for XFOR.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 3.5 USD (-2.78%) |
| 52-week range | 3.19 USD – 4.82 USD |
| Trend regime | Range |
| 14-day RSI | 16.1 (Oversold) |
| Trailing P/E | -0.81 |
| Market cap | 0.35B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-06 |
Available research for XFOR
Covered Call on XFOR: how it works, illustrative setup around the real 3.5 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on XFOR: how it works, illustrative setup around the real 3.5 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on XFOR: how it works, illustrative setup around the real 3.5 USD price, max profit/loss, breakeven and when to use it. Educational.
XFOR technical analysis: range, last 3.5 USD, RSI 16.1, 52w range 3.19 USD–4.82 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is XFOR in?
X4 Pharmaceuticals (XFOR) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is XFOR in an uptrend or downtrend?
As of 2026-09-11, XFOR is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is XFOR's trailing P/E ratio?
XFOR's trailing P/E is -0.81, with a market cap of 0.35B. See the earnings research page for full valuation detail.
When does XFOR next report earnings?
XFOR is next scheduled to report earnings on 2026-08-06, with a consensus EPS estimate of -0.19 USD.